Home › Down Syndrome › Minnesota
Down Syndrome clinical trials in Minnesota
3 studies for Down Syndrome are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
RecruitingPhase 2
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
RecruitingObservational study
Ages 6 to 39 · All sexes · Updated Aug 25, 2026 · NCT05702645Collaboration for Down Syndrome Progress (CDP)
- University of Minnesota, Minneapolis
RecruitingObservational study
All ages · All sexes · Updated Jun 4, 2026 · NCT07625579From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.